SPO-NDS: Fueling Precision Oncology in Switzerland

“Multidimensional datasets are playing an increasingly important role in guiding treatment decisions in precision oncology. The Swiss Personalised Oncology (SPO) initiative aims to integrate clinical, molecular, and imaging data to support decision-making within molecular tumor boards. To this end, a national infrastructure has been established to collect and harmonize interoperable data across all Swiss University Hospitals and selected non-University Centres. In parallel, standardized multi-omics workflows have been implemented across these institutions to support treatment recommendations at both local and national levels. Illustrative examples will be presented to demonstrate how the integration of clinical, imaging, and multi-omics data can inform therapeutic strategies and improve patient care.”